Assignee
RAPT THERAPEUTICS INC
US·12 granted patents·9 pending applications·24 citations·filing 2018–2025
Top patents by PatentIndex Score
21 records- 0194US10683280B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·8 cites·22 claims
- 0293US11384064B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Jul 12, 2022·3 cites·28 claims
- 0392US11192879B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·3 cites·28 claims
- 0487US10604526B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·2 cites·25 claims
- 0585US12428393B2Methods of making trans isomeric forms of G protein-coupled receptor modulatorsRAPT THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·1 cites·13 claims
- 0683US2025059167A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0781US11046699B2Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic usesRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·3 cites·46 claims
- 0881US2024199620A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0978US11084829B2Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·2 cites·55 claims
- 1077US12098139B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 1177US11730736B2Anticancer agentsRAPT THERAPEUTICS INC·Filed 2018·Granted Aug 22, 2023·2 cites·15 claims
- 1273US2024317768A1Crystalline forms of c-c chemokine receptor type 4 antagonist and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1371US12240837B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·42 claims
- 1471US2026092049A1Methods of making trans isomeric forms of g protein-coupled receptor modulatorsRAPT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1569US2025034115A1Crystalline forms of c-c chemokine receptor type 4 antagonist and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1666US12006318B2Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Jun 11, 2024·0 cites·46 claims
- 1766US2020239480A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1862US2025122208A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1959US2026092050A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2053US11918582B2Pyrazole pyrimidine compounds and uses thereofRAPT THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·0 cites·57 claims
- 2148US2021317134A1Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →